Results 71 to 80 of about 15,946 (160)
Prevalence and Spectrum of Chronic Liver Disease Among Patients Seeking Health Care in Ghana
ABSTRACT Background Chronic liver diseases (CLD) leading to liver fibrosis and cirrhosis are a major cause of morbidity and mortality in sub‐Saharan Africa and pose a significant burden on its health care systems. We aimed to elucidate the prevalence of fibrosis/cirrhosis in patients seeking health care in Kumasi, Ghana, and its underlying aetiologies.
Felix Lehmann +19 more
wiley +1 more source
Introduction: Treatment strategies for chronic hepatitis B (CHB) using either interferon or Lamivudine can achieve sustained response in 30-40 % in HBeAg positive CHB.
Deepak N. Amarapurkar, Nikhil D. Patel
doaj +1 more source
Introduction: Hepatitis B virus (HBV) infection remains a significant global health challenge, annually contributing to approximately one million deaths from complications such as liver failure, cirrhosis, and hepatocellular carcinoma (HCC). Methods: This observational, descriptive, cross-sectional study was conducted at the Armed Forces Institute of ...
Dr. (Major) Samia Mahmood +3 more
openaire +1 more source
HBeAg negative chronic hepatitis B in South Asia
Chronic Hepatitis B (CHB) infection has an intermediate prevalence rate in South Asian countries, except for Nepal and Sri Lanka where it has a low rate. HBeAg negative CHB infection has been found to be more pronounced in this part of the world.
Ananta Shrestha +6 more
doaj +1 more source
Time trends of HBeAg prevalence rate.
わが国のHBVキャリアにおけるHBe抗原陽性率の年次推移を明らかにするために,年齢階級別,出生コーホート別に観察した.1) 1977年1月から84年3月の間に,大阪府赤十字血液センターが取扱ったHBs抗原陽性の献血者,男23,560人,女8,659人を調査対象とした.2) 性,年齢階級別にHBe抗原陽性率の年次推移を観察すると,男女とも近年HBe抗原陽性率が低下しつつあったが,特に,10歳代,20歳代でその傾向が著しかった.3) HBe抗原陽性率は,年齢とともに低下したが,同じ年齢階級でも出生年代が若くなるにつれて,HBe抗原陽性率は低くなった.4) 以上から,わが国のHBVキャリアにおけるHBe抗原陽性率は,今後も低下傾向を持続すると推測された.
Hideaki TSUKUMA +4 more
openaire +2 more sources
Background/Aims: We aimed to investigate the clinical importance of quantitative levels of serum hepatitis B surface antigen (HBsAg) and hepatitis B e antigen (HBeAg), and to detect their correlation with hepatitis B virus (HBV) DNA load, alanine ...
Kaan Demirören +2 more
doaj +1 more source
Introduction: Chronic hepatitis B (CHB) is associated with high burden and healthcare costs. Virologic response achieved with an-tivirals is associated with progression avoidance.
Itziar Oyagüez +4 more
doaj +1 more source
Background: Hepatitis B virus (HBV) infection is a serious public health issue that must be addressed. Aim: The goal of this study was to investigate the correlation between serological status for hepatitis Be antigen (HBeAg)/anti-HBe, serum transaminase
Manoj Kumar +6 more
doaj +1 more source
BackgroundHBeAg seroconversion is an important intermediate outcome in HBeAg-positive chronic hepatitis B (CHB) patients. This study aimed to compare the effect of nucleos(t)ide analogs (NAs) on HBeAg seroconversion in treating CHB with lamivudine ...
Tongjing Xing +3 more
doaj +1 more source
Hepatitis B virus (HBV) is a major cause of chronic liver disease and an important public health issue. This study was conducted with the objective of evaluating the histological features in patients infected with precore and wild-type HBV infection; compare the histological activity and fibrosis stage and early treatment of HBeAg negative hepatitis ...
A J, Tarafder, M, Chowdhury, S, Rahman
openaire +1 more source

